Introduction
This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs
Features and benefits
- Gain insight into Roche's strategic outlook across the next 6 years
- Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source
Highlights
Strategic insight into the prospects for Roche over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales
Your key questions answered
- Benchmark Roche's performance against key rivals in the prescription pharmaceutical sector
- Assess the importance of Genentech-sourced products to the future top-line performance of the Roche Group
- Discover the impact of Roche's desire to re-enter the primary care market, away from its current hospital care focus